Reply to the Editor  by Vinograd, Itzhak
The options available to treat pediatric air-
way obstruction include surgical resection
and anastomosis (including slide tracheo-
plasty), silicone (eg, Dumon) stents, Mont-
gomery T-tubes, and SEMS. Recently, there
has been a disturbing trend of using SEMS
as the first option in treating benign tracheo-
bronchial pathology, primarily because of
the ease of deployment and the dramatic
relief of obstruction in the short term.2 We
feel that it needs to be reiterated strongly
that SEMS should remain the last resort in
patients with benign stenosis or those with
a surgically correctable airway obstruction.
SEMS have a number of complications that
are difficult to treat long-term. The ideal
indication for SEMS is a patient with ter-
minal malignancy with airway obstruction
in whom the expected low survival from
the primary malignancy precludes the oc-
currence of stent-related complications.
SEMS cause intense granulation tissue,
which often causes the same symptoms for
which the stent was deployed; subsequent
attempts to alleviate this problem with la-
ser, electrocautery, and so on usually have
disappointing results. Moreover, contrary
to the authors’ views, removal of these
stents is difficult and fraught with danger.
Single and short-segment tracheal stenosis
should be treated by primary surgery in
centers experienced in pediatric tracheal
surgery. Stenting should be reserved for
patients in an acute situation (where sili-
cone stents may be deployed as a tempo-
rary measure) before referral to a center
specializing in tracheal surgery.
Although not practical in infants and
very small children, Dumon stents and
Montgomery T-tubes are invaluable in
stenting lesions that are too long for safe
reconstruction.3 More often than not, the
stent stabilizes the airway, and decannula-
tion is possible in most cases.4 Moreover,
the ease with which silicon stents can be
removed if definitive surgery is being con-
sidered makes it an attractive option to tide
over an acute situation. The pediatrician,
pulmonologist, or thoracic surgeon in-
volved in managing complex airway prob-
lems needs to be aware of the basic under-
lying pathology and intelligently apply the
right solution to a specific problem.
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Reply to the Editor:
In my article I emphasized that the use of
intratracheal stents in children is dangerous
and carries the risk of severe complications.
With regard to the use of self-expandable
metallic stents (SEMS), I completely agree
that their use should be avoided. There are
enough data in the literature to support
this.1 The SEMS in this study were made
from nitinol, an alloy with a “shape mem-
ory effect.” In animal studies, this stent,
because of its unique biochemical property,
could he fixed and removed easily, even in
very small airways.2 In children, their use
was associated with an excessive granula-
tion, and although the extraction proved to
be easy and smooth, their application is
currently suspended.
Currently available silicone or Dumoan
stents have an external diameter that pre-
vents their use in infants and small chil-
dren.
The Montgomery and I-tubes could be
an option in tracheal strictures, but they are
not practical in bronchial or distal airway
problems.
I would like to thank Mr Pramesh for
his remarks.
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Molecular changes occurring with
aneurysm formation: Possible impact
of sampling error
To the Editor:
We congratulate Cotrufo and colleagues1
for exploring messenger RNA expression
and extracellular matrix protein content
in the ascending aorta associated with
bicuspid aortic valves (BAVs), with par-
ticular attention to differences between
the inner and outer curvatures. Our lab-
oratory is also exploring the molecular
changes occurring with aneurysm forma-
tion, and we have been concerned about
the potential impact of sampling error on
experimental results.
Cotrufo and colleagues1 demonstrated dif-
ferences in levels of collagens I, III, and IV, as
well as fibronectin and laminin protein, by
western blot analysis when comparing samples
taken from the concave and convex portions of
dilated aortas resected from patients with BAV.
Additionally, they reported differences between
patients with functionally regurgitant versus ste-
notic valves. Importantly, Cotrufo and col-
leagues1 also reported significant differences in
protein levels between dilated aortas (regardless
of functional valve pathology) and normal con-
trol aortas. Indeed, these differences were as
striking as those observed between concavity
and convexity or between stenotic and regurgi-
tant specimens.
We too are intrigued by the observations
made on aneurysmal tissues, but we urge
caution in interpreting the comparisons made
between dilated aortas and the control group.
A marked difference in age may have pro-
foundly impacted results. Cotrufo and col-
leagues1 reported mean ages for the regurgi-
tation, stenosis, and control groups as 56 9,
59 12, and 33 8 years, respectively. The
95% confidence intervals for these groups
(from data provided in the article’s on-line
Table E11) were 51.2-61.4, 50.9-66.4, and
24.6-41.4 years, respectively. The difference
in collagen expression led Cotrufo and col-
leagues1 conclude that “collagen degradation
by proteinases could prevail over collagen
synthesis” and that smooth muscle cells
“could react differently to different types and
degrees of mechanical stress and could favor,
in turn, a predominant production of either
ECM [extracellular matrix] proteins or pro-
teolytic enzymes.” An alternative hypothesis
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